Therapeutic potency of transduction with herpes simplex virus thymidine kinase gene against multidrug resistant mouse leukemia cells

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 681-686

  Takenaga, Keizo ^a   Tagawa, Masatoshi ^a,b   Sakiyama, Shigeru ^a  

^a CHIBA CANCER CENTER   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Ganciclovir; Herpes simplex virus; Multidrug resistance; Thymidine kinase

Indexed keywords

DOXORUBICIN; GANCICLOVIR; THYMIDINE KINASE; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SENSITIVITY; EXPERIMENTAL NEOPLASM; GENE THERAPY; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA P 388; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GANCICLOVIR; GENE THERAPY; LEUKEMIA P388; MICE; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION; VINCRISTINE;

EID: 0029945087     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Endicott JA and Ling V: The biochemistry of P-glycoprotein-mediated multidrug resistance. Annti Rev Biochem 58: 137-171, 1989.
2. Pastan I and Gottesmann MM: Multiple-drug resistance in human cancer. N Engl J Med 316: 1388-1393, 1987.
3. Tsuruo T: Mechanism of multidrug resislance and implications for therapy. Jpn J Cancer Res 79: 285-296, 1988.
4. Harris AL and Hochhauser D: Mechanisms of multidrug resistance in cancer treatment. Acta Oncologica 31: 205-213, 1992.
5. Biedler JL.: Genetic aspects of multidrug resistance. Cancer (Suppl.) 70: 1799-1809, 1992.
6. Ford JM and Hait WN: Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42: 155-199, 1990.
7. Moscow JA and Cowan KH: Multidrug resistance. J Natl Cancer Inst 80: 14-20, 1988.
8. Van der Bliek AM and Borst P: Multidrug resistance. Adv Cancer Res 52: 165-203, 1989.
9. Shinoda H, Ebisu H, Mitsubishi J, Inaba M and Tsuruo. T: Therapeutic efficacy of combination of antitumor agent with AHC-52 against multidrug-resistant cells in the intravenously inoculated P388 leukemia model. Cancer Chemother Pharmacol 30: 335-340, 1992.
10. Naito M, Oh-hara T, Yamazaki A, Danki T and Tsuruo. T: Reversal of multidrug resistance by an immunosuppressive agent FK-506. Cancer Chemother Pharmacol 29: 195-200, 1992.
11. Raderer M and Scheithauer W: Clinical Trials of agents that reverse multidrug resistance. A literature review. Cancer 72: 3553-3563, 1993.
12. Gutierrez AA, Lemoine NR and Sikora K: Gene therapy for cancer. Lancet 330:115-721, 1992.
13. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH and Blaese M: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550-1552, 1992.
14. Chen S-H, Shine D, Goodman C, Grossman RG and Woo SLC: Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 91: 3054-3057, 1994.
15. Takamiya Y, Short MP, Ezzeddine ZD, Moolten FL, Breakefield XO and Martuza RL: Gene therapy of malignant brain tumors: A rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J Neurosci Res 33: 493-503, 1992.
16. Moolten FL and Wells JM: Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82: 297-300, 1990.
17. Moolten FL: Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res 46: 5276-5281, 1986.
18. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann J-L and Klatzmann D: Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 90: 7024-7028, 1993.
19. Raymond M, Rose E, Housman DE and Gros P: Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells. Mol Cell Biol 10: 1642-1651, 1990.
20. Wilkoff LJ and Dulmadge EA: Resistance and cross-resistance of cultured leukemia P388 cells to vineristine, adriamycin, adriamycin analogs and actinomycin D. J Natl Cancer Inst 61: 1521-1524, 1978.
21. Inaba M, Fujikura R and Sakurai Y: Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia. Biochem Pharmacol 30: 1863-1865, 1981.
22. Tsuruo T, Iida H, Tsukagoshi S and Sakurai Y: Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41: 1967-1972, 1981.
23. Fyfe JA, Keller PM, Furman PA, Miller RL and Elion GB: Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J Biol Chem 253: 8721-8727, 1978.
24. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.